Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis
NCT: NCT07122518 · RECRUITING
Publicidad
ID NCTNCT07122518
EstadoRECRUITING
Fecha de inicio2026-06-23
SponsorCordis US Corp. (INDUSTRY)
First posted
Last updated
Resumen breve
The purpose of the clinical investigation is to characterize clinical outcomes and to assess the real-world use of the commercial PALMAZ MULLINS XD™ Pulmonary Stent.
Fuente oficial
Ver en ClinicalTrials.gov →Datos obtenidos de la API de ClinicalTrials.gov. Para conocer el estado más reciente, consulte el registro oficial.